Andexanet alfa therapy showed No increased rate of thromboembolic events in spontaneous intracranial hemorrhage patients: A multicenter electronic health record study
Authors:
- John VellekJVJohn Vellek
- Omar H. TarawnehOTOmar H. Tarawneh
- Syed Faraz KazimSKSyed Faraz Kazim
- Oluwafemi P. OwodunniOOOluwafemi P. Owodunni
- Sophia ArbuisoSASophia Arbuiso
- Smit ShahSSSmit Shah
- Alis J. DicpinigaitisADAlis J. Dicpinigaitis
- Meic H. SchmidtMSMeic H. Schmidt
- Rohini G. McKeeRMRohini G. McKee
- Richard MiskiminsRMRichard Miskimins
- Fawaz Al-MuftiFAFawaz Al-Mufti
- Christian A. BowersCBChristian A. Bowers
Open Access
- 27 March 2024
- journal article
- editorial
- Published by Elsevier in World Neurosurgery: X
- Vol. 23
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Risk of intracranial hemorrhage after carotid artery stenting versus endarterectomy: a population-based studyJournal of Neurosurgery, 2018
- Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USADrugs & Therapy Perspectives, 2018
- Management of Factor Xa inhibitor-associated life-threatening major hemorrhage: A retrospective multi-center analysisThe American Journal of Emergency Medicine, 2018
- Current evidence of oral anticoagulant reversal: A systematic reviewThrombosis Research, 2018
- Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: a review of design, development and potential place in therapyJournal of Thrombosis and Thrombolysis, 2018
- National Trends in Ambulatory Oral Anticoagulant UseThe American Journal of Medicine, 2015
- Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathyThrombosis Research, 2012
- Antithrombotic Therapy in the ElderlyJACC, 2010
- Coding of Stroke and Stroke Risk Factors Using International Classification of Diseases , Revisions 9 and 10Stroke, 2005
- Deep vein thrombosisNeurology, 2004